Special reports Archives - Parkinson's Life

Special reports

In the second in our series, we explore the debate
READ MORE
Special reports

We explore the debate surrounding Parkinson’s and animal testing
READ MORE
Special reports

More than 7300 male veterans took part in the study
READ MORE

Parkinson’s and animal testing: the case against

In the second in our series, we explore the debate

Do we have the right to test Parkinson’s medications on animals?

We explore the debate surrounding Parkinson’s and animal testing

Age, smoking and lack of fitness increase risk of Parkinson’s

More than 7300 male veterans took part in the study

Parkinson’s drugs may lead to compulsive behaviours such as gambling

The study tested 411 people over a three year period

A single head injury could increase risk of Parkinson’s

A study has found a link between head injuries and Parkinson’s

woman talking with business colleagues in office

STEP – The lived experience of Parkinson’s disease

STEP™ hopes to give a voice to people living with Parkinson’s

Crowded sidewalk on Oxford Street in London

Parkinson’s prevalence expected to increase by 18% in next seven years

Aging UK population could see increase in Parkinson’s over time

Neurological disorders – including Parkinson’s – are leading source of disability globally

Parkinson’s is world’s fastest growing neurological disorder

£16,000 a year: the hidden price of Parkinson’s

Research reveals the monetary cost of Parkinson’s for UK families

Muhammad Ali’s death “has raised Parkinson’s awareness”

Muhammad Ali’s legacy lives on

How close are we to a Parkinson’s breakthrough? Three experts have their say

Renowned experts give their opinions on the next breakthrough

100 for Parkinson’s: patients suffer lower moods, higher stress levels and poorer sleep quality

Latest findings from 100 for Parkinson’s study released

Paws for thought: dogs sniff out Parkinson’s disease with 90% hit rate

Dogs have been trained to sniff out Parkinson’s disease

High blood pressure, arthritis and depression are most common conditions in Parkinson’s patients

“We cannot gather too much data”

More than a third of Parkinson’s patients hide symptoms “out of fear or shame”

Parkinson’s patients “too afraid” to reveal diagnosis

Why we should treat this ‘damaging’ study on physiotherapy in Parkinson’s with caution

President of APPDE calls PD REHAB trial “damaging”

How virtual reality is giving Parkinson’s patients a ‘disease-free’ Second Life

Second Life: a (virtual) world without Parkinson’s

Are we too focused on the search for a Parkinson’s cure?

We ask Parkinson’s experts for their views on this controversial debate

Lewy body dementia: “The worst of Parkinson’s and Alzheimer’s together”

Shedding light on the dementia often mistaken for Parkinson’s

“Brain Surgery Live is a modern medical miracle the public deserved to see”

Exposure for such modern miracles is crucial, argues Justin Rossi

The future generation of advanced therapies for Parkinson’s

Dr Kieran Breen explores the potential of stem cell & gene therapies

Neurologists should be ‘guides not gods’ – Part 2

Top expert Bastiaan Bloem argues the case for a more holistic approach

Parkinson’s and depression: It’s not all in your mind

Depression may be common among PwPs, but it's not a sign of weakness

Neurologists should be ‘guides not gods’ – Part 1

Why physicians need to come down from their 'ivory towers'

Could a transplant lower the risk of Parkinson’s?

Researchers at Washington University School of Medicine, US, have found that having a heart, kidney, lung or bone marrow transplant could reduce the risk of developing Parkinson’s. As part of the study, published in medical journal ‘Parkinsonism & Related Disorders’, the team assessed data of just under 200,000 patients – 89,790 of whom had Parkinson’s. The results revealed that individuals who had a transplant were 37% less likely to develop Parkinson’s. This could be due to the immunosuppressant medication patients receive before undergoing a transplant, which researchers believe may help slow neurodegeneration as it reduces inflammation in the brain. The study said: “This study provides evidence that tissue transplant may be associated with a lower PD [Parkinson’s disease] risk, warranting further investigation to identify factors that mediate this relationship.”

Groundbreaking Parkinson’s trial publishes results

A breakthrough Parkinson’s trial that featured in a two-part documentary on UK television channel BBC Two has published its results. The study, which featured in the documentary ‘The Parkinson’s Drug Trial: A miracle cure?’, aimed to investigate whether it was possible to restore damaged neurons by administering protein Glial Cell Line Derived Neurotrophic Factor (GDNF). As part of the trial, scientists initially infused GDNF into the brains of six participants living with the condition. Researchers then invited a further 35 individuals with Parkinson’s to take part, with approximately half being administered with a placebo infusion. Although not conclusive, the results suggest that GDNF had an impact on the brain and researchers believe the topic is worthy of further study. Dr Alan Whone, principal investigator on the trial, said: “This represents some of the most compelling evidence yet that we may have a means to possibly reawaken and restore the dopamine brain cells…

Course for Parkinson’s nurses launches in Slovenia

The International Parkinson and Movement Disorder Society is hosting its third summer school for nurses specialising in Parkinson’s. The course – which will be held from 10-12 May in Ljubljana, Slovenia – will focus on the management of the motor and non-motor symptoms of the condition. Students will also attend lectures, examine Parkinson’s patients and discuss treatment plans with experts. All lectures will be presented in English. Heather Vitale, senior programme manager at the International Parkinson and Movement Disorder Society, said: “This course offers a unique opportunity for nurses to enhance their knowledge in Parkinson’s disease, while also learning and networking with their peers through case study presentations and small group discussions.” Registration closes 26 April 2019 and costs USD $350.

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Comments
This field is for validation purposes and should be left unchanged.

Parkinson’s and animal testing: the case against

Do we have the right to test Parkinson’s medications on animals?

Age, smoking and lack of fitness increase risk of Parkinson’s

Special reports

Special reports

Special reports

Parkinson’s and animal testing: the case against

Do we have the right to test Parkinson’s medications on animals?

Age, smoking and lack of fitness increase risk of Parkinson’s

Parkinson’s drugs may lead to compulsive behaviours such as gambling

A single head injury could increase risk of Parkinson’s

sponsored article

STEP – The lived experience of Parkinson’s disease

Parkinson’s prevalence expected to increase by 18% in next seven years

Neurological disorders – including Parkinson’s – are leading source of disability globally

£16,000 a year: the hidden price of Parkinson’s

Muhammad Ali’s death “has raised Parkinson’s awareness”

How close are we to a Parkinson’s breakthrough? Three experts have their say

100 for Parkinson’s: patients suffer lower moods, higher stress levels and poorer sleep quality

Paws for thought: dogs sniff out Parkinson’s disease with 90% hit rate

High blood pressure, arthritis and depression are most common conditions in Parkinson’s patients

More than a third of Parkinson’s patients hide symptoms “out of fear or shame”

Why we should treat this ‘damaging’ study on physiotherapy in Parkinson’s with caution

How virtual reality is giving Parkinson’s patients a ‘disease-free’ Second Life

Are we too focused on the search for a Parkinson’s cure?

Lewy body dementia: “The worst of Parkinson’s and Alzheimer’s together”

“Brain Surgery Live is a modern medical miracle the public deserved to see”

The future generation of advanced therapies for Parkinson’s

Neurologists should be ‘guides not gods’ – Part 2

Parkinson’s and depression: It’s not all in your mind

Neurologists should be ‘guides not gods’ – Part 1

{categories}

{title}

Could a transplant lower the risk of Parkinson’s?

Groundbreaking Parkinson’s trial publishes results

Course for Parkinson’s nurses launches in Slovenia

{title}

Subscribe

Sign in